Elizabeth Arden, Inc. (NASDAQ:RDEN)

CAPS Rating: 2 out of 5

The Company is a manufacturer, marketer and designer of fragrances, skin treatment and cosmetic products, to customers in the United States and internationally.

Results 1 - 14 of 14

Recs

0
Member Avatar pchop12316 (86.35) Submitted: 8/20/2014 10:15:16 AM : Outperform Start Price: $15.21 RDEN Score: +10.86

price just too attractive to miss this opportunity

Recs

1
Member Avatar RugbyViking13 (91.61) Submitted: 7/12/2012 9:50:42 PM : Outperform Start Price: $38.92 RDEN Score: -105.33

they make women smell good... i like it

Recs

0
Member Avatar Ironbob (70.89) Submitted: 12/16/2011 5:38:58 PM : Outperform Start Price: $25.75 RDEN Score: -89.13

I'll pay just to watch that Red Door commercial over and over.

Recs

0
Member Avatar morriss003 (30.16) Submitted: 1/14/2011 2:48:21 PM : Outperform Start Price: $24.41 RDEN Score: -84.92

It gets a lot of its revenue from China and is likely to increase revenue.

Recs

0
Member Avatar ElleRB (90.67) Submitted: 2/9/2010 3:20:26 PM : Underperform Start Price: $17.11 RDEN Score: +86.20

It seems to me that Elizabeth Arden is creeping downhill. During a recent visit to one of the spas, I was disappointed by chintzy materials, cheap products, and sub-par service. Without real elegance, luxury, or quality, I worry that the company will lost the cache necessary to keep this stock on an upward swing.

Recs

0
Member Avatar springfieldcolor (82.50) Submitted: 1/17/2009 9:47:06 PM : Outperform Start Price: $6.71 RDEN Score: +11.50

38% dip..will atleast expect it to go 5-10% north in coming weeks

Recs

0
Member Avatar yellowsmurf27 (< 20) Submitted: 5/29/2008 2:27:22 PM : Outperform Start Price: $15.76 RDEN Score: -39.48

The type of stock helps me to believe that this will outperform it's competitors.

Recs

0
Member Avatar LilBoo000 (< 20) Submitted: 5/2/2008 9:49:20 AM : Outperform Start Price: $13.99 RDEN Score: -24.66

The stock still has solid fundamentals and a strong customer base. I think it is oversold and a good buy at this price.

Recs

0
Member Avatar JohnStuartMill1 (39.46) Submitted: 3/12/2008 9:12:29 AM : Outperform Start Price: $18.22 RDEN Score: -63.53

Low PEG. Stock will rise to the market.

Recs

0
Member Avatar GabeCaps (79.50) Submitted: 2/5/2007 12:22:38 PM : Outperform Start Price: $20.98 RDEN Score: -65.55

They've had a bad year, and have been beaten up by acquisition troubles. I think they're ready for new heights.

Recs

2
Member Avatar NetscribeConsGds (97.90) Submitted: 1/22/2007 6:51:46 AM : Underperform Start Price: $17.89 RDEN Score: +53.20

Smell a rat on Elizabeth Arden. It is an US based beauty products company engaged in the manufacturing and marketing of fragrances, skin care products and cosmetic products worldwide. In addition to over 100 owned and licensed prestige brands, the company also distributes over 200 additional prestige fragrance brands principally to mass retailers in the United States. Fragrances contribute around 75% of the sales followed by skincare and cosmetics.

The life cycle of fragrances has shortened dramatically in recent years. Loyalty towards the brand is declining and more and more customers are experimenting with different brands within a short span. Hence, companies are launching new products at a very faster rate to meet the market demand. To face the industry challenges, Elizabeth Arden has been incurring huge marketing spends and undergoing promotional activities, which is finally grinding down the bottom lines of the company. The company did generate about 12% rise in revenues in the first quarter of fiscal 2007 driven by sale of new brands and acquisitions of Riviera and Sovereign. However, revenues are rising at the cost of spiraling expenses. In the past two quarters, the company financials has gone in the red and costs are likely to rise ahead on account of marketing expenses and acquisition related integration costs.

Conversely, management is upbeat on their ‘Prevage’ skin care line as demand for anti-aging products is rising. However on the negative side, revenues could take a hit due to Wal-Mart’s shift in the product mix, as Elizabeth Arden currently derives significant revenues from Wal-Mart. Also, it is expecting the benefit of acquisitions to materialize later in 2008. Considering these facts, the scrip does not look an exciting investment from one-year perspective.

Recs

0
Member Avatar schubper (33.61) Submitted: 11/16/2006 8:30:04 PM : Outperform Start Price: $18.40 RDEN Score: -59.13

Undervalued take-over candidate

Recs

0
Member Avatar MCKInathan (96.18) Submitted: 11/5/2006 11:04:17 PM : Outperform Start Price: $18.38 RDEN Score: -62.30

Price is right to buy. Holiday season should boost sales of beauty products and I like the company's management.

Recs

1
Member Avatar keagankn (87.02) Submitted: 9/28/2006 7:00:00 PM : Outperform Start Price: $16.07 RDEN Score: -52.73

Elizabeth Arden is the way to go for beauty. They're dominating the fragrance market, and slowly taking over the creams/cosmetics markets also. Their wide range of products appeal to any demographic, and who can really say no to a face like Catherine Zeta-Jones?

Results 1 - 14 of 14

Featured Broker Partners


Advertisement